https://www.facebook.com/1310451392143005/

Leading Lifestyles, 114 FL 60 #352, Lake Wales, FL (2026)

09/10/2026

STOP EXERCISING JUST TO BURN CALORIES.

One of the biggest mistakes I see during weight loss is treating exercise like punishment for eating.

“I ate too much yesterday, so I need extra cardio.”

“I burned 500 calories, so now I can eat this.”

That's not how I want my clients thinking about training.

If you're trying to lose a significant amount of weight, resistance training has another incredibly important job:

Give your body a reason to KEEP its muscle.

Your calorie deficit drives weight loss.

Your protein intake helps provide the building blocks.

Your resistance training tells your body:

“We still need this muscle.”

So instead of judging every workout by how many calories your watch says you burned, start tracking:

🏋️ Weight lifted
🔁 Reps performed
💪 Strength improvements
🚶 Daily steps
📆 Training consistency

You don't need to destroy yourself in the gym.

You need a program you can progress and repeat consistently.

Fat loss gets you lighter.

Maintaining muscle helps change what you look and perform like when you get there.

Train for the body you want to KEEP—not just the calories you want to burn.

09/10/2026

One of the biggest mistakes I made when I was almost 300 pounds was thinking I had to be perfect.

I'd have one bad meal and immediately think…
‘Well, I screwed up. I'll start again Monday.’

But that one meal wasn't what was stopping my progress.
It was turning that one meal into a bad day… then a bad weekend… and sometimes a bad week.

Losing 115 pounds taught me something:

You don't need to be perfect. You just need to stop quitting every time you're not.

Have the meal. Enjoy it.

Then get right back to your normal routine with the next meal.
That's something I wish I knew before losing 115 pounds.

09/10/2026

🚨 BEYOND WEIGHT LOSS: GLP-1 RESEARCH IS BECOMING A LOT BIGGER THAN THE SCALE

Another interesting development happened today.

China has approved semaglutide (Wegovy) for MASH — metabolic dysfunction-associated steatohepatitis, a serious form of fatty liver disease that can cause inflammation and liver scarring.

And this isn't the first development like this.

In the United States, Wegovy already has an FDA indication for adults with MASH and moderate-to-advanced liver fibrosis without cirrhosis.

Why is this interesting?

Because the GLP-1 conversation is increasingly moving beyond:

“How much weight can someone lose?”

Researchers and regulators are looking at outcomes involving:

❤️ Cardiovascular health
🫀 Liver disease
😴 Sleep apnea
🩺 Metabolic health
⚖️ Obesity and its complications

But there's an important distinction.

This does NOT mean GLP-1 medications cure every metabolic disease.

Different medications have different indications, different levels of evidence, and some potential benefits being discussed online are still only being researched.

That's exactly why I started Beyond Weight Loss.

Instead of repeating headlines, I want to separate:

✅ What's actually been demonstrated
🔬 What's still being studied
❌ What's being exaggerated online

Because understanding the research is a lot more useful than simply hearing that something is “good for you.”

📚 Sources:

• Reuters — September 10, 2026: Novo Nordisk says Wegovy approved in China for liver disease MASH

• U.S. FDA / Wegovy Prescribing Information — MASH indication

• Endocrine Society — September 2026 Scientific Statement: Obesity science, research gaps, and opportunities in the new era of obesity medicines

09/09/2026

🚨 BEYOND WEIGHT LOSS: GLP-1s & HEART DISEASE ❤️

Most people still think of GLP-1 medications primarily as weight-loss drugs.

But cardiovascular disease is one area where the science has already moved beyond the number on the scale.

One of the biggest pieces of evidence came from the SELECT trial, published in The New England Journal of Medicine.

Researchers followed 17,604 adults who had overweight or obesity AND established cardiovascular disease — but did not have diabetes.

The results were significant:

📊 Major cardiovascular events — cardiovascular death, nonfatal heart attack or nonfatal stroke — occurred in 6.5% of participants receiving semaglutide versus 8.0% receiving placebo.

That translates to approximately a 20% relative reduction in risk for the combined cardiovascular endpoint.

But here's the important part when we talk about research versus proven indications:

✅ WHAT IS ACTUALLY FDA-APPROVED?

On March 8, 2024, the FDA approved Wegovy (semaglutide) to reduce the risk of cardiovascular death, heart attack and stroke in adults with established cardiovascular disease who also have overweight or obesity.

And the current FDA prescribing information continues to include reduction of major adverse cardiovascular events as an approved indication.

So in this specific population, cardiovascular risk reduction isn't simply an interesting theory being investigated anymore.

It's an FDA-approved indication.

🔬 WHAT ARE SCIENTISTS STILL STUDYING?

There are still some BIG questions.

Researchers continue investigating:

➡️ How much of the cardiovascular benefit comes from weight loss itself versus other biological effects.

➡️ The potential roles of inflammation, blood pressure, metabolic improvements and vascular function.

➡️ Whether cardiovascular benefits extend to broader populations who don't already have established cardiovascular disease.

And cardiovascular disease is only one piece of this story.

We're now seeing GLP-1 research extend into the kidneys, liver disease, sleep apnea, cardiovascular health and other areas of metabolic disease.

That's exactly why I'm starting this series.

BEYOND WEIGHT LOSS will separate the hype from the evidence:

✅ What's FDA-approved
🔬 What's actually being studied
📊 What the clinical trials really found

Because there's a HUGE difference between “research suggests” and “the FDA has approved.”

Follow along — tomorrow we'll look at another area where this research is moving Beyond Weight Loss.

📚 SOURCES / FURTHER READING

• U.S. Food & Drug Administration — Current Wegovy Prescribing Information (2026): The current label lists reduction of cardiovascular death, nonfatal heart attack and nonfatal stroke in adults with established cardiovascular disease and overweight or obesity as an indication.

• Lincoff AM, et al. — SELECT Trial, New England Journal of Medicine (2023): Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. 17,604 participants; cardiovascular events occurred in 6.5% with semaglutide versus 8.0% with placebo (HR 0.80).

• McGuire DK, et al. — SOUL Trial, New England Journal of Medicine (2025): Additional cardiovascular-outcomes research found a lower rate of major cardiovascular events with oral semaglutide versus placebo in people with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both.

Educational content only. Medication decisions and individual cardiovascular risk should be discussed with a qualified healthcare professional.

09/01/2026

🚨 YOU PROBABLY DON’T NEED MORE MOTIVATION.

You’ve been motivated before.

You’ve started the diet.
Joined the gym.
Bought the meal-prep containers.
Told yourself, “This time I’m serious.”

Then life happened.

Work got crazy.
The kids needed you.
You missed a few workouts.
Nutrition slipped.

And eventually you were back at square one.

The problem may not be motivation.

It may be the lack of a system.

At Leading Lifestyles, we help you build one around YOUR life:

🥩 Nutrition targets you can actually follow
🏋️ Training designed around your schedule
📲 Coaching and accountability
📊 Progress tracking and adjustments
🧠 Habits built for the long game

You don't need to be perfect.

You need a plan you can keep following when life isn't.

Stop waiting for another Monday.

🔥 BUILD THE PLAN. BUILD THE HABITS. BUILD YOUR COMEBACK.

Ready for some structure?

Send me “COMEBACK” and let's talk.

— Leading Lifestyles
Transform Your Body. Lead Your Life.

09/01/2026

🚨 YOUR MUSCLES MAY ACTUALLY RELEASE THEIR OWN “TRAINING SIGNAL.”

New research published in Nature Communications found that working muscle produces L-BAIBA, a metabolite that appears to play a role in how muscles adapt to exercise.
In mice, L-BAIBA was linked to improved:

💪 Exercise performance
🔥 Energy metabolism
⚡ Fatigue resistance
🔋 Mitochondrial function

Researchers also found L-BAIBA increased in humans after endurance training and was associated with better aerobic fitness.

⚠️ Important: The strongest evidence is still animal/preclinical research. This does not show that taking L-BAIBA as a supplement improves performance or muscle growth in humans.
The takeaway?

Exercise does much more than burn calories. Training triggers an entire cascade of biological signals that help your body adapt.

🏋️ Train. 🥩 Fuel. 😴 Recover. 🔁 Repeat.
👇 Would you take an “exercise pill” if science could someday replicate some of these benefits?

08/26/2026

🚨 **GLP-1 USERS: THE SCALE DOESN'T TELL THE WHOLE STORY.**

New research is reinforcing something I talk about all the time:

**Losing weight and improving your body composition are NOT necessarily the same thing.**

A new systematic review and meta-analysis looked at GLP-1 and GLP-1/GIP medications in adults with overweight or obesity.

Yes—the peptides can produce substantial weight loss.

But when body weight comes down, some of that loss can also come from **lean mass**, not just body fat.

And that's why I don't believe a successful weight-loss plan should simply be:

💉 use GLPs
🍽️ Eat way less
⚖️ Watch the scale drop

We should also be asking:

💪 Are you resistance training?

🥩 Are you eating enough protein?

🏃 Are you staying physically active?

📏 Is your waist/body fat decreasing?

🏋️ Are you maintaining your strength?

Because the goal isn't simply to become a **smaller version of yourself.**

The goal should be to lose excess body fat while preserving as much **muscle, strength and function** as possible.

GLP-1's can be an incredibly powerful tool.

But peptides + nutrition + resistance training + lifestyle?

**That's where body transformation gets much more interesting.**

Stop chasing the lowest number on the scale.

**Start chasing better body composition. 💪**

👇 If you're losing weight right now, are you tracking anything besides the scale?

*Educational content only. Medication and nutrition decisions should be discussed with an appropriate healthcare professional.*

08/26/2026

🚨 EXERCISE MAY NOT BE THE BEST TOOL FOR LOSING WEIGHT… BUT IT COULD BE ONE OF THE BEST TOOLS FOR KEEPING IT OFF.

This is an important distinction that gets lost in the “just exercise more” weight-loss conversation.

A research summary published August 22 reviewed evidence showing that physical activity often has a relatively modest effect on initial weight loss.

Why? Your body can compensate: appetite can increase, you may subconsciously move less afterward, and energy expenditure can adapt over time.

But here's where exercise becomes incredibly important:

A study involving more than 1,100 people found that physical activity had little relationship with how much weight people initially lost—but higher activity after weight loss was strongly associated with maintaining that loss.

💪 WHY MIGHT EXERCISE HELP PREVENT WEIGHT REGAIN?

Regular activity can help:

🏋️ Preserve or rebuild muscle
🔥 Support daily energy expenditure
🩸 Improve insulin sensitivity and blood-sugar control
⚡ Improve the body's ability to use fat for energy
❤️ Improve cholesterol and inflammation markers

And resistance training deserves special attention.

When we lose significant weight, we typically lose some muscle along with fat. Preserving muscle helps maintain strength, function and resting energy expenditure.

⚠️ EVIDENCE CHECK

This isn't a new randomized clinical trial proving that exercise guarantees you'll never regain weight. The August 22 publication is an evidence-based research commentary summarizing previous human research, including observational associations.

So we shouldn't interpret it as:

❌ “Exercise doesn't help with weight loss.”

A better interpretation is:

Nutrition may create much of the initial calorie deficit. Exercise becomes especially valuable for your health, body composition and long-term weight maintenance.

💡 PRACTICAL TAKEAWAY

If you've already lost 20, 50 or 100+ pounds, reaching your goal weight isn't the finish line.

That's when training may become even more important.

🥩 Prioritize adequate protein.
🏋️ Keep resistance training.
🚶 Stay active outside the gym.
📈 Maintain or improve your strength.
⚖️ Build habits you can continue after the “diet” ends.

Don't just build a plan that helps you lose the weight.

Build a lifestyle that makes it easier to KEEP IT OFF. 💪

👇 Which do you think is harder: losing the weight or keeping it off for 5+ years?

08/24/2026

THE SCALE GOING DOWN ISN’T THE ONLY GOAL.

Weight loss can be exciting.

But losing weight and improving your body composition, strength, fitness, and habits aren't always the same thing.

A successful transformation should be about more than chasing the lowest number possible.

At Leading Lifestyles, we focus on helping you build the foundation:

💪 Strength training
🥩 Adequate protein
🥗 Better nutrition habits
🚶 More daily movement
📊 Consistent progress tracking
🧠 Habits you can actually maintain

Whether you're pursuing weight loss through lifestyle changes alone or working with a healthcare professional who has incorporated additional tools into your plan, the fundamentals still matter.

Don't just chase weight loss.

Build a stronger, healthier lifestyle you can continue after the weight comes off.

🔥 LOSE THE WEIGHT. KEEP THE STRENGTH. BUILD THE LIFESTYLE.

Ready for more structure and accountability?

Send me “TRANSFORM” and let's talk.

— Leading Lifestyles
Transform Your Body. Lead Your Life.

Educational only. Leading Lifestyles provides fitness and nutrition coaching and does not provide medical care or prescribe medications.

Leading Lifestyles

09/10/2026

09/10/2026

09/10/2026

09/09/2026

09/01/2026

09/01/2026

08/26/2026

08/26/2026

08/24/2026

Address

Website

Alerts

Shortcuts

Share

Category

Listing takedown request